Inventor · disambiguated record
Kyle Mcelearney
Also filed as: MCELEARNEY KYLE · MCELEARNEY KYLE SHAMUS
3 granted patents·6 pending applications·5 citations·filing 2014–2022
58Inventor score
Top patents by PatentIndex Score
9 records- 0186US9944968B2Control of protein glycosylation by culture medium supplementation and cell culture process parametersBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·4 cites·31 claims
- 0278US10676772B2Control of protein glycosylation by culture medium supplementation and cell culture process parametersBIOGEN MA INC·Filed 2018·Granted Jun 9, 2020·1 cites·28 claims
- 0356US2024279704A1Using fucosidase to control afucosylation level of glycosylated proteinsAMGEN INC·Filed 2022·Application pending·0 cites
- 0450US2016237399A1Control of Protein Glycosylation by Culture Medium Supplementation and Cell Culture Process ParametersBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 0545US2022048984A1Mammalian Cell Culture-Produced Neublastin AntibodiesGLORIANA THERAPEUTICS SARL·Filed 2019·Application pending·0 cites
- 0641US10717965B2Mammalian cell culture-produced neublastin antibodiesGLORIANA THERAPEUTICS SARL·Filed 2018·Granted Jul 21, 2020·0 cites·17 claims
- 0739US2015353883A1Medium Supplements for Improved Process PerformanceBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 0835US2017327786A1Hypotaurine, GABA, Beta-Alanine, and Choline for Control of Waste Byproduct Accumulation in Mammalian Cell Culture ProcessBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 0934US2017029859A1Medium supplements for improved process performanceBIOGEN MA INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kyle Mcelearney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →